Sorrento Therapeutics COVID-19 Pipeline Update, R&D Discussion and Management Q&A Transcript

Oct 13, 2020 / 08:30PM GMT
Operator

Good afternoon and welcome to Sorrento's COVID-19 Pipeline R&D Day. (Operator Instructions). At this I'd like to turn the call over to Alexis Nahama, SVP, corporate development at Sorrento. Please proceed.

Alexis Nahama - Sorrento Therapeutics - SVP of Corporate Development

Thank you. Good afternoon and evening everyone. Thank you for joining the Sorrento COVID R&D day call. Before we begin, please note that this presentation will include forward looking statements with the meaning of the federal securities laws, which are made, [for instance], to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

This forward looking statements reflect Sorrento's current judgment and expectations as of today and involve the number of assumptions, risk and uncertainties and actual results may differ materially.

Accordingly, you should not place any reliance on these statements. Please see our SEC filings for important risk factors that could cause our actual performance and results to differ materially from those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot